NDC 0615-8151
Lovastatin 20 mg tablet
On the label: NCS HealthCare of KY, Inc dba Vangard Labs. It's repackaged: NCS HealthCare of KY, Inc dba Vangard Labs rebottles it from Lupin Pharmaceuticals, Inc.'s NDC 68180-468.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lupin Limited | Salcette, India | Makes it and packages it | Problems found, fixed voluntarilyNov 21, 2025 · 9 inspections, 1 with FDA action |
Repackaging site
- NCS HealthCare of KY, LLC dba Vangard Labs, Glasgow, KY, United States · repackages it
Recalls
- Feb 13, 2019 · Class III · Lupin Pharmaceuticals Inc.
CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.
Lots: Lot #: a) G702755, Exp March 2020; b) G702756, Exp March 2020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lovastatin: every company that makes it
- Form
- tablet, oral
- Strength
- 20 mg
- Approval
- ANDA ANDA078296
- On the market since
- Jul 9, 2018
- Package NDCs
0615-8151-39- Official label
- DailyMed (National Library of Medicine), updated Aug 5, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?